In a compelling editorial published in the 18th volume of Aging-US, researchers Jochen Mierau and Marco Demaria, both affiliated with the University of Groningen and the European Research Institute for the Biology of Ageing (ERIBA), articulate a forward-looking vision that urges coordinated, multi-layered interventions across the entire life course. They argue that the historic gains in human lifespan were driven primarily not by cutting-edge medical technologies but by broad public health initiatives addressing environmental determinants of health such as sanitation, occupational safety, housing, vaccination, and education. While these pillars remain fundamental, the authors emphasize the pressing need to extend not just lifespan but healthspan—the period of life marked by robust health and functional independence.

Central to this editorial is the notion that modern aging societies contend with complex, cumulative health risks emanating from lifelong exposures to environmental toxins, ultra-processed diets, tobacco, alcohol, sedentary behavior, psychosocial stress, and climate-related disruptions. These factors contribute to accelerated biological aging, which manifests as systemic vulnerability to a constellation of chronic diseases. The authors highlight that such interconnected exposures defy the effectiveness of isolated, disease-specific treatments and instead call for integrated public health and clinical strategies aligned with mechanisms of biological aging.

Scientific advances increasingly spotlight core molecular and cellular processes driving aging, including cellular senescence, chronic inflammation (inflammaging), metabolic dysregulation, and impaired protein homeostasis (proteostasis). Longevity-directed interventions targeting these pathways promise a revolutionary approach, potentially delaying or mitigating a spectrum of age-associated diseases simultaneously. By focusing on biological aging itself, rather than solely treating discrete pathologies as they arise, these therapies could redefine the trajectory of aging and disease onset.

Nonetheless, Mierau and Demaria caution against viewing longevity interventions as replacements for established public health or clinical medicine. Instead, they advocate for a synergistic framework that incorporates preventive public health measures to minimize baseline risks, traditional clinical medicine to manage established disease, and longevity-focused therapies aimed at decelerating biological decline prior to clinical manifestation. This life course-integrated model is visually encapsulated in Figure 1 of their paper, illustrating how layered interventions can collectively bolster resilience and functional health.

Implementing such a comprehensive strategy necessitates overcoming formidable challenges. Accurate, reliable biomarkers of biological aging are essential to stratify individuals, monitor intervention efficacy, and tailor therapies. Equitable access must be prioritized to ensure that benefits of longevity science do not exacerbate existing health disparities. Furthermore, regulatory frameworks must evolve to accommodate novel aging-targeted therapeutics, and health systems need strengthening to sustainably incorporate prevention-focused approaches. The editorial stresses that outcome measures should expand beyond traditional endpoints like mortality and incidence rates, incorporating metrics such as physical function, cognitive capacity, resilience, and independence.

Longevity science is rapidly maturing, with preclinical and early clinical studies targeting pathways like senolytics (agents that selectively eliminate senescent cells), anti-inflammatory compounds, and metabolic modulators showing promising results. These interventions hold the potential not only to delay age-related morbidities but also to enhance overall physiological robustness. Integrating these advances into public health frameworks offers a transformative opportunity to reimagine how societies promote healthy aging.

Furthermore, the editorial recognizes that the biological and social determinants of aging are inseparable. Social isolation, economic inequality, and environmental stressors influence biological aging and health outcomes profoundly. Thus, public health policies must adopt a systems-level approach, addressing social, behavioral, and environmental factors in concert with biomedical innovations. This holistic perspective aligns with an emerging consensus that lifespan extension should be accompanied by improved quality of life and sustained autonomy.

There is also a critical dialogue surrounding ethical, legal, and social implications (ELSI) of introducing longevity interventions at scale. Questions of resource allocation, consent, intergenerational equity, and societal readiness must be confronted proactively. These discussions are vital to ensure that longevity science contributes to a just and inclusive vision of public health.

As populations worldwide age, fostering resilience becomes paramount. The authors propose redefining resilience not just as recovery from illness but as sustained capacity to maintain function and adapt to physiological stressors over time. Public health systems that prioritize early prevention, promote biological health, and support adaptive capacities may yield dividends in reducing healthcare burdens and enhancing population wellbeing.

In summary, Mierau and Demaria’s editorial illuminates a pivotal moment in public health, urging a paradigm shift from reactive, disease-centered care to proactive, system-wide resilience built upon the integration of traditional public health, clinical medicine, and cutting-edge longevity interventions. This integrated approach aims to extend human healthspan as much as lifespan, ensuring that longer lives are both productive and meaningful. The framework they propose marks a critical blueprint for future research, policy, and practice as societies navigate the complexities of aging in the 21st century and beyond.

Article Title: Public health in the age of longevity interventions: from prevention to system-wide resilience

News Publication Date: May 18, 2026

Web References: https://doi.org/10.18632/aging.206381

Image Credits: Copyright © 2026 Mierau and Demaria. Distributed under Creative Commons Attribution License (CC BY 4.0).

Keywords: aging, healthy longevity, biological aging, public health, cellular senescence, healthspan

China’s demographic transformation presents an unparalleled challenge to healthcare infrastructures worldwide. The nation, home to the world’s largest elderly population, grapples with a rising prevalence of chronic diseases, disability, and cognitive impairment among older adults. Complex needs arise when these conditions coexist or when social determinants intensify health vulnerabilities. Zhang and colleagues approached this multifaceted problem by analyzing real-world data to map out distinct utilization profiles among elders requiring both medical intervention and long-term supportive care.

Employing latent class analysis—a sophisticated statistical method designed to classify subjects into mutually exclusive subgroups based on observed variables—the study identified underlying patterns of service use that conventional analysis often overlooks. This model-based clustering approach unveiled latent categories representing different care utilization phenomenologies, enabling an unprecedented understanding of heterogeneity within this population. Such granularity is critical for tailoring interventions and resources effectively.

The cross-sectional design incorporated comprehensive data from community health records, inpatient and outpatient service use, and long-term care facility engagements. Importantly, the study emphasized real-world evidence, reflecting true conditions beyond controlled trial settings or administrative claims alone. This methodological rigor ensures that conclusions drawn are both pragmatic and immediately relevant for policy stakeholders and service providers.

Findings revealed at least four distinct latent classes, each characterized by unique mixes of healthcare service consumption and dependency indicators. One subgroup demonstrated predominantly outpatient care utilization with sporadic long-term assistance, suggesting relatively preserved function but chronic disease management needs. Another group showed intensive, continuous institutional care reliance indicative of severe functional decline and advanced multimorbidity.

Notably, the research illuminated disparities in access and utilization shaped by socioeconomic status, urban-rural divides, and familial support structures. Older adults residing in rural settings or with limited financial resources tended to fall into classes marked by underutilization of preventive and rehabilitative services. Conversely, urban dwellers with better insurance coverage accessed more diversified and frequent care options, highlighting systemic inequalities even within a universal healthcare framework.

This segmentation model presents transformative implications for health policy. By identifying latent service utilization archetypes, systems can shift from one-size-fits-all approaches to bespoke intervention strategies, optimizing resource allocation to improve outcomes. For example, community health programs can prioritize outreach toward underrepresented groups to bridge gaps in early detection and chronic disease management.

Moreover, the study underscores the necessity of integrated care delivery models that bridge medical and long-term care sectors. The blended profile of certain latent classes points to the interdependence between health management and social support systems. Policymakers are urged to dismantle silos and foster interdisciplinary coordination, ensuring seamless transitions between hospital-based procedures and home or facility-based long-term care.

Beyond the immediate clinical sphere, Zhang et al. contribute vital insights into caregiving dynamics. The research captures the burden placed on family caregivers and the influence of cultural expectations on care choices. Understanding these human factors is crucial for designing support mechanisms that respect both elder autonomy and caregiver well-being.

As China accelerates its commitment to healthy aging frameworks and social security reform, empirical evidence from this study acts as a beacon guiding sustainable policy trajectories. It calls for enhanced data infrastructure to capture real-time utilization patterns and the incorporation of advanced analytics in routine decision-making.

From a global perspective, the implications reverberate across nations confronting similar demographic shifts. Zhang and colleagues provide a replicable analytic paradigm adaptable to varied contexts, encouraging international collaboration around shared challenges in geriatric care.

Future research inspired by these findings could explore longitudinal trajectories, assessing how shifts in health status influence class membership and service needs over time. Investigations into technological innovations, such as telemedicine or AI-driven care monitoring, have promise for addressing some barriers identified within latent subgroups.

In summary, this meticulous exploration into the real-world medical and long-term care utilization of older adults with complex needs elucidates critical heterogeneity previously masked by aggregate data. The fusion of advanced statistical techniques with robust real-life datasets exemplifies the power of interdisciplinary research in advancing geriatric medicine and public health. Zhang et al.’s contribution paves the way for more nuanced, compassionate, and equitable healthcare designs poised to serve aging societies better now and in the future.

Subject of Research: Patterns of medical and long-term care service utilization among elderly individuals with complex health needs in China.

Article Title: Real-world medical and long-term care service utilization patterns among older adults with complex needs in China: a latent class analysis.

Article References:
Zhang, P., Zhu, B., Zhang, Y. et al. Real-world medical and long-term care service utilization patterns among older adults with complex needs in China: a latent class analysis. BMC Geriatr (2026). https://doi.org/10.1186/s12877-026-07611-7

Image Credits: AI Generated

As populations worldwide continue to age rapidly, the imperative to promote healthy ageing has never been more pressing. The aging demographic in Greece, a country with a high percentage of elderly citizens, accentuates challenges in healthcare delivery and sustainability. Against this backdrop, a cutting-edge initiative emerges, framed by the World Health Organization’s Integrated Care for Older People (ICOPE) protocol, tailored into the Joint Action on Prevention of Non-Communicable Diseases (JA PreventNCD) framework. This innovative approach marks a significant stride toward enhancing the quality of life for older adults through early detection, timely intervention, and comprehensive community-based care strategies.

The WHO ICOPE protocol represents a pivotal advancement in geriatric healthcare, providing structured guidelines that prioritize functional ability and intrinsic capacity rather than simply focusing on disease management. This paradigm shift supports the concept that preserving physical, mental, and social capacities can meaningfully delay institutionalization and dependency. By integrating ICOPE within PreventNCD—a robust European initiative aimed at curbing the burden of chronic diseases—the Greek context becomes a fertile ground for deploying a multidimensional, evidence-based model of care.

Tapping into the Greek national health infrastructure, the implementation of the ICOPE protocol under the PreventNCD umbrella emphasizes person-centered care, mobilizing multidisciplinary teams that include physicians, nurses, social workers, and community health agents. This broadened healthcare tessellation aims to anticipate and mitigate functional decline through continual assessment of domains such as mobility, cognition, nutrition, vision, hearing, and mental health. The capacity to generate real-time data on these critical determinants allows for rapid and customized interventions.

Biological aging is inherently heterogeneous, influenced by genetics, environmental exposures, lifestyle, and comorbidities. The ICOPE protocol acknowledges this complexity by recommending standardized screenings that reflect the multidimensionality of aging. Greece’s deployment showcases how local adaptations—taking into account socioeconomic disparities, urban-rural divides, and cultural factors—enhance the practicality and acceptance of the protocol across diverse populations. Digital health tools and telemedicine platforms further empower healthcare providers to reach marginalized elderly populations, facilitating continuous monitoring and engagement.

One of the most notable aspects of the Greek ICOPE-PreventNCD integration is its capacity to address the escalating epidemic of non-communicable diseases (NCDs) among older adults. Cardiovascular diseases, diabetes, chronic respiratory conditions, and neurodegenerative disorders present both a clinical challenge and substantial economic strain. Through proactive functional evaluations and personalized preventive strategies, the initiative aims to forestall disability onset, promote resilience, and extend healthspan.

Besides the clinical angles, the synergy between public health policies and community-based interventions fosters a supportive ecosystem for the elderly. Local governments and non-governmental organizations (NGOs) collaborate to improve accessibility to health services and social support. Programs oriented towards physical activity promotion, nutritional counseling, and mental wellness are integral complements to the ICOPE-guided clinical encounters, showcasing a holistic approach to healthy aging.

Research efforts underpinning the protocol’s adaptation in Greece provide compelling evidence of the protocol’s effectiveness and scalability. Pilot studies reflect promising outcomes in maintaining functional capacities, reducing hospital admissions, and enhancing patient-reported quality of life metrics. These data points encourage policymakers to endorse broad rollouts nationally and potentially extend the model across Southern Europe, where aging populations face comparable healthcare challenges.

Technology integration serves as a cornerstone for success. Utilizing wearable sensors, mobile health applications, and electronic health records allows continuous collection and analysis of intrinsic capacity parameters. This digital ecosystem facilitates predictive analytics, enabling healthcare providers to intervene before irreversible decline sets in. Additionally, continuous education programs ensure that healthcare professionals are proficient in leveraging these advanced tools aligned with ICOPE metrics.

Yet, challenges remain, including overcoming resistance to change in clinical workflows, ensuring data privacy, and addressing digital literacy deficiencies among elderly users. The Greek pilot consciously embeds training modules for caregivers and patients alike, fostering an inclusive environment where older adults actively participate in managing their health trajectory. Such empowerment constitutes a vital element in achieving sustainable, person-centered care.

Financial sustainability and policy alignment are critical to the long-term success of the WHO ICOPE initiative in Greece. The integration within the JA PreventNCD framework benefits from European Union support, linking healthy aging directly to chronic disease prevention and health promotion strategies. This alignment optimizes resource allocation, reduces redundancy, and leverages existing public health infrastructures effectively.

The cultural dimension also plays a significant role. Greece’s strong family traditions and social networks provide a natural foundation for community-oriented aging solutions. The protocol’s design recognizes the importance of social engagement and mental health, integrating assessments of psychological wellbeing alongside physical health. This approach counters loneliness, depression, and cognitive impairments prevalent in ageing populations, further solidifying the comprehensive nature of care.

In spotlighting Greece’s commitment to advancing healthy ageing, this initiative also sets a global example. The combination of WHO’s evidence-based protocol with the JA PreventNCD framework illustrates how international collaborations and tailored national implementations can together reshape aging paradigms. Greece’s strategy offers a blueprint for other nations striving to enhance elderly care amid rising chronic disease burdens and shifting demographic profiles.

A crucial takeaway from the Greek ICOPE implementation highlights the significance of early intervention and prevention. By shifting healthcare focus upstream—prioritizing intrinsic capacity maintenance before severe decline—the model envisaged by WHO and JA PreventNCD holds promise in alleviating strain on specialized geriatric and acute care services. This not only improves individual outcomes but also fosters systemic efficiencies with profound socio-economic implications.

Furthermore, the success of Greece’s integrated approach buttresses the importance of multisectoral engagement. Healthcare professionals, policymakers, technologists, communities, and older adults themselves all have vital contributions to make toward realizing the vision of healthy ageing. By promoting shared ownership and responsibility, the model cultivates resilience within healthcare systems and societies confronting the realities of population ageing.

As this initiative advances toward full national implementation, longitudinal monitoring and impact assessments will provide crucial insights, shaping refinement and scaling strategies. Continuous feedback loops between clinical practice, technological innovation, and community engagement ensure that the evolving needs of Greece’s ageing population are met with agility, compassion, and scientific rigor.

Ultimately, the intersection of the WHO ICOPE protocol with the JA PreventNCD framework in Greece exemplifies a forward-thinking, integrative approach to healthy ageing. It embodies a shift from fragmented, disease-centric models toward inclusive, proactive systems that preserve function and dignity for older adults. This transformative paradigm promises to inspire global efforts to reimagine aging and deliver equitable, sustainable health outcomes in the 21st century and beyond.

Subject of Research: Advancing healthy ageing through integrated care protocols targeting functional ability and non-communicable disease prevention in older adults in Greece.

Article Title: Advancing healthy ageing in Greece: the WHO ICOPE protocol within the JA PreventNCD framework.

Article References:
Adamakidou, T., Koreli, A., Tavassoli, N. et al. Advancing healthy ageing in Greece: the WHO ICOPE protocol within the JA PreventNCD framework. BMC Geriatr (2026). https://doi.org/10.1186/s12877-026-07488-6

Image Credits: AI Generated

Polypharmacy, broadly defined as the concurrent use of multiple medications, is a common phenomenon among the elderly due to the frequent coexistence of chronic illnesses such as hypertension, diabetes, cardiovascular diseases, and cognitive disorders. However, excessive polypharmacy is a double-edged sword; while it aims to control and mitigate pathological conditions, it dramatically raises the risk of adverse drug reactions, drug-drug interactions, and medication non-adherence, leading to hospitalization, functional decline, and diminished quality of life.

The cohort examined in this study, consisting exclusively of individuals aged 80 years and above, is particularly susceptible to the complexities of polypharmacy. Age-related physiological changes—such as reduced renal and hepatic function, altered body composition, and changes in receptor sensitivity—profoundly modulate pharmacokinetics and pharmacodynamics, often rendering standard medication dosages inappropriate or unsafe. This reality necessitates an in-depth evaluation of prescribed medications to ensure therapeutic efficacy while minimizing harm.

The research systematically delineates the frequency and characteristics of potentially inappropriate medications, as identified by widely accepted criteria such as the Beers Criteria and STOPP/START guidelines. These tools help in highlighting drugs whose risks outweigh their benefits in the elderly, either due to the increased risk of side effects, duplication of therapy, or because safer alternatives exist.

This investigative effort revealed that a significant proportion of the elderly subjects were prescribed at least one PIM, pointing to a persistent gap in optimized pharmacotherapy for the oldest old. Importantly, this trend is not solely a reflection of higher disease burden but also implicates deficiencies in medication review processes, clinical inertia, and fragmentation in care coordination among geriatric healthcare providers.

What emerges forcefully from the study is the imperative role of interprofessional collaboration in mitigating polypharmacy risks. Pharmacists, geriatricians, primary care physicians, and nursing staff must engage in continuous dialogues, leveraging electronic health records and decision-support tools to rigorously scrutinize ongoing medication regimes, identify redundancies, and deprescribe when clinically justified.

Furthermore, the findings emphasize the utility of comprehensive geriatric assessment (CGA) in personalizing pharmacological therapy. A CGA encompasses evaluation of functional status, cognitive function, comorbidities, nutritional state, and psychosocial context, enabling clinicians to balance the necessity of therapeutic interventions against the vulnerability to adverse effects within the complex aging physiology.

Technology-driven interventions also surfaced as promising adjuncts to traditional clinical assessments. Artificial intelligence and machine learning models, integrated with clinical databases, hold potential in predicting high-risk patients, suggesting safer medication alternatives, and prompting timely medication reconciliation practices.

The study underscores that beyond the clinical ramifications, inappropriate polypharmacy in octogenarians exerts a substantial socioeconomic toll, manifesting in increased healthcare utilization, prolonged hospital stays, and escalated costs for health systems already grappling with aging populations. Proactive medication management strategies could thus represent not only a clinical imperative but also a cost-containment opportunity.

Amidst this multifaceted challenge, patient engagement merits particular attention. Educating elderly patients and their caregivers about the purpose and potential side effects of each medication fosters adherence and empowers shared decision-making. Patients who understand their therapeutic regimens can better report adverse effects and participate actively in deprescribing discussions, culminating in safer, individualized care plans.

While the prevalence of PIMs remains concerning, the authors of this research suggest that targeted educational programs for healthcare professionals, coupled with policy reforms promoting routine medication review and deprescribing protocols, could significantly reduce inappropriate prescriptions in this age group.

The impact of coexisting mental health conditions on medication complexity was also highlighted. Conditions such as dementia, depression, and anxiety often necessitate psychotropic drugs, which are fraught with high risks in the elderly, further complicating risk-benefit analyses.

Notwithstanding the comprehensive nature of the study, the authors call for longitudinal research to monitor the outcomes of deprescribing interventions and the development of predictive models tailored to the oldest old demographics. This future research trajectory is essential for evolving guidelines that are dynamically responsive to the growing heterogeneity of geriatric patients.

Ultimately, the insights provided by this study resonate as a clarion call to enhance geriatric pharmacotherapy through precision medicine principles, rigorous clinical oversight, and patient-centered approaches. By doing so, healthcare systems can strive not only to extend lifespan but more importantly, to enrich the healthspan of the most aged members of society.

This compelling body of evidence should galvanize stakeholders—from policymakers to practicing clinicians—to prioritize medication safety and efficacy in octogenarians, ensuring that the twilight years are not shadowed by the preventable consequences of medication mismanagement.

Subject of Research: Evaluation of polypharmacy and potentially inappropriate medication use among geriatric individuals aged 80 years and older.

Article Title: Evaluation of polypharmacy and potentially inappropriate medication use among geriatric individuals aged 80 years and older.

Article References:
Beler, M., Yakar, B., Beler, Z. et al. Evaluation of polypharmacy and potentially inappropriate medication use among geriatric individuals aged 80 years and older. BMC Geriatr (2026). https://doi.org/10.1186/s12877-026-07505-8

Image Credits: AI Generated